{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:34:14Z","timestamp":1792679654038,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Immigrant Minority Health"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Viral hepatitis is a global health care challenge due to its worldwide distribution, chronic persistence, complications, and high prevalence with unchecked conditions in areas like sub-Saharan Africa. A high proportion of asymptomatic infections allows serious complications and poses infection risk to destination populations. This study aimed to determine the prevalence of both HBV and HCV among 3248 migrants from different parts of sub-Saharan Africa newly arrived  at\u00a0Kufra, Libya, a remote agricultural North African city. All these migrants were required by the Libyan authorities to undergo a complete medical check-up for different purposes such as joining  new jobs, and  obtaining licenses for trade and commerce. UAT sera from 3248 migrants, aged 18\u201353\u00a0years, attending the Al Kufra city hospital from January 01 to December 31, 2019, were screened for HBsAg and anti-HCV antibody by rapid tests and positive samples were further tested by ELISA method. The results showed that 761\/3248 (23.4%) of the migrants were positive for HBV and 1014\/3248 (31.2%) were positive for HCV. Migrants from sub-Saharan Africa carry high rates of HBV and HCV infection. This suggests the importance of increased attention to actions to deal with findings among positive migrants, and for awareness about risks of transmission to the local population. Study results indicate the value of routine migrant monitoring, the need for awareness in destination country health authorities, and the potential for impact on migrant destination populations.\n<\/jats:p>","DOI":"10.1007\/s10903-022-01448-z","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T09:02:44Z","timestamp":1673686964000},"page":"882-888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of Hepatitis B and Hepatitis C in Migrants from Sub-Saharan Africa Before Onward Dispersal Toward Europe"],"prefix":"10.1007","volume":"25","author":[{"given":"Frhat M. A.","family":"Saaed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0339-8942","authenticated-orcid":false,"given":"Jerry E.","family":"Ongerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"key":"1448_CR1","unstructured":"CDC, 2021. Centers for disease control and prevention (CDC). Global viral hepatitis: millions of people are affected. https:\/\/www.cdc.gov\/hepatitis\/global\/index.htm#ref01. (Accessed 7 Dec 2021)."},{"issue":"9","key":"1448_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","volume":"10","author":"B Hajarizadeh","year":"2013","unstructured":"Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10(9):553\u201362.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1448_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s11901-010-0060-4","volume":"9","author":"S Jamma","year":"2010","unstructured":"Jamma S, Hussain G, Lau DT. Current concepts of HBV\/HCV coinfection: coexistence, but not necessarily in harmony. Curr Hepat Rep. 2010;9(4):260\u20139.","journal-title":"Curr Hepat Rep"},{"issue":"1","key":"1448_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2009.11.009","volume":"14","author":"HS Te","year":"2010","unstructured":"Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14(1):1\u201321.","journal-title":"Clin Liver Dis"},{"issue":"12","key":"1448_CR5","doi-asserted-by":"publisher","first-page":"17428","DOI":"10.1086\/421268","volume":"38","author":"BD Gushulak","year":"2004","unstructured":"Gushulak BD, MacPherson DW. Globalization of infectious diseases: the impact of migration. Clin Infect Dis. 2004;38(12):17428.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1448_CR6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ijheh.2019.04.006","volume":"222","author":"FMA Saeed","year":"2019","unstructured":"Saeed FMA, Ongerth JE. Giardia and cryptosporidium in children with diarrhea, Kufra Libya, a North African migration route city. Int J Hyg Environ Health. 2019;222(5):840\u20136.","journal-title":"Int J Hyg Environ Health"},{"issue":"2","key":"1448_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jhep.2015.04.026","volume":"63","author":"S Sharma","year":"2015","unstructured":"Sharma S, Carballo M, Feld JJ, Janssen HL. Immigration and viral hepatitis. J Hepatol. 2015;63(2):515\u201322.","journal-title":"J Hepatol"},{"key":"1448_CR8","doi-asserted-by":"publisher","DOI":"10.1515\/9780691187235","volume-title":"The hunt for a killer virus","author":"BS Blumberg","year":"2002","unstructured":"Blumberg BS, Hepatitis B. The hunt for a killer virus. Princeton: Princeton University Press; 2002."},{"issue":"Suppl 1","key":"1448_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01925.x","volume":"29","author":"M Houghton","year":"2009","unstructured":"Houghton M. Discovery of the hepatitis C virus. Liver Int. 2009;29(Suppl 1):82\u20138. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01925.x.","journal-title":"Liver Int"},{"key":"1448_CR10","unstructured":"Mukherjee S and Dhavan V. Hepatitis C. eMed J 2004. Available from URL: http\/www.e medicine.com\/ gastroentrology\/hepatitisC."},{"key":"1448_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","volume":"64","author":"C Seeger","year":"2000","unstructured":"Seeger C, Mason WS. Hepatitis B virus biology. Micro Mol Biol Rev. 2000;64:51\u201368.","journal-title":"Micro Mol Biol Rev"},{"key":"1448_CR12","unstructured":"World Health Organization.\u00a0(2021).\u00a0Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact: web annex 1: key data at a glance.\u00a0World Health Organization.\u00a0https:\/\/apps.who.int\/iris\/handle\/10665\/342808. (Accessed 10 Jan 2022)."},{"key":"1448_CR13","unstructured":"UNHCR. Ethiopia refugee response plan; 2018. p. 1\u201368."},{"issue":"1","key":"1448_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2893.1999.6120139.x","volume":"6","author":"WHO","year":"1999","unstructured":"WHO. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat. 1999;6(1):35\u201347.","journal-title":"J Viral Hepat"},{"key":"1448_CR15","unstructured":"UNHCR, 2018. Mixed migration routes and dynamics in Libya in 2018. United Nations, high commission on refugees, 2019. Available at: https:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/impact_lby_report_mixed_migration_routes_and_dynamics_in_2018_june_2019.pdf. (Accessed 11 Jan 2022)."},{"key":"1448_CR16","unstructured":"Torelli, SM, 2018. Migration through the Mediterranean: mapping the EU response. European council on foreign relations (ECFR.eu), April 2018. https:\/\/ecfr.eu\/special\/mapping_migration\/# (Accessed 2 Jan 2022)."},{"issue":"12","key":"1448_CR17","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.116.","journal-title":"Vaccine"},{"key":"1448_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)6141","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk R, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015. https:\/\/doi.org\/10.1016\/S0140-6736(15)6141.","journal-title":"Lancet"},{"issue":"1333","key":"1448_CR19","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(1333):1342. https:\/\/doi.org\/10.1002\/hep.26141.","journal-title":"Hepatology"},{"key":"1448_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/0035-9203(94)90082-5","volume":"88","author":"MG Saleh","year":"1994","unstructured":"Saleh MG, et al. High prevalence of hepatitis C virus in the normal Libyan population. Trans R Soc Trop Med Hyg. 1994;88:292\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1448_CR21","unstructured":"ECDC. Epidemiological assessment of hepatitis B & C among migrants in the EU\/EEA. Stockholm: ECDC; 2016. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/epidemiological-assessment-hepatitis-B-and-C-among-migrants-EU-EEA.pdf (Accessed 10 Jan 2021)."},{"key":"1448_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12889-015-1476-0","volume":"15","author":"JA Owiti","year":"2015","unstructured":"Owiti JA, et al. Illness perceptions and explanatory models of viral hepatitis B & C among migrants and refugees: a narrative systematic review. BMC Public Health. 2015;15:151.","journal-title":"BMC Public Health"},{"issue":"3","key":"1448_CR23","first-page":"59","volume":"7","author":"J Howell","year":"2014","unstructured":"Howell J, Ladep NG, Lemoin M, Thursz MR, Taylor-Robinson SD. Hepatitis B in sub-Saharan Africa. S Sudan Med J. 2014;7(3):59\u201361.","journal-title":"S Sudan Med J"},{"issue":"10003","key":"1448_CR24","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0140-6736(15)61116-3","volume":"386","author":"JH MacLachlan","year":"2015","unstructured":"MacLachlan JH, Locarnini S, Cowie BC. Estimating the global prevalence of hepatitis B. Lancet. 2015;386(10003):1515\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(15)61116-3.","journal-title":"Lancet"},{"key":"1448_CR25","unstructured":"CDC. Epidemiology and prevention of vaccine-preventable diseases (The pink book). 10th edition. Waldorf (MD): Public Health Foundation; 2008."},{"key":"1448_CR26","volume-title":"Yellow book chapter 4-hepatitis B, 2020: health information for international travel","author":"CDC","year":"2017","unstructured":"CDC. Yellow book chapter 4-hepatitis B, 2020: health information for international travel. New York: Oxford University Press; 2017."},{"key":"1448_CR27","volume-title":"Yellow book chapter 4-hepatitis C, 2020: health information for international travel","author":"CDC","year":"2017","unstructured":"CDC. Yellow book chapter 4-hepatitis C, 2020: health information for international travel. New York: Oxford University Press; 2017."},{"key":"1448_CR28","unstructured":"Abdulaziz Q. Alodini. Prevalence of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Infections among Blood Donors at Al-Thawra Hospital Sana\u2019a City-Yemen. Yemeni Journal for Medical Sciences (2012)."},{"issue":"4","key":"1448_CR29","first-page":"330","volume":"16","author":"S Ahmed","year":"1984","unstructured":"Ahmed S, Sanyal R, Scedrou P, Ahmed M. Hepatitis B surface antigen in South Sudan. J Commun Disord. 1984;16(4):330\u20131.","journal-title":"J Commun Disord"},{"key":"1448_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/1743-422X-7-334","volume":"7","author":"A Ali","year":"2010","unstructured":"Ali A, Ahmad H, Ali I, Khan S, Zaidi G, Idrees M. Prevalence of active hepatitis C virus infection in district Mansehra Pakistan. Virol J. 2010;7:334.","journal-title":"Virol J"},{"issue":"2","key":"1448_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1478-3231.2005.01054.x","volume":"25","author":"R Burnett","year":"2005","unstructured":"Burnett R, Francois G, Kew M, Leroux-Roels G, Meheus A, Hoosen A, et al. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int. 2005;25(2):201\u201313.","journal-title":"Liver Int"},{"issue":"4","key":"1448_CR32","first-page":"597","volume":"25","author":"SA Junejo","year":"2009","unstructured":"Junejo SA, Khan NA, Lodhi AA. Prevalence of hepatitis B and C infection in patients admitted at tertiary eye care centre: a hospital-based study. Pak J Med Sci. 2009;25(4):597\u2013600.","journal-title":"Pak J Med Sci"},{"issue":"1","key":"1448_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jmv.1890240110","volume":"24","author":"H Kefene","year":"1988","unstructured":"Kefene H, Rapicetta M, Rossi G, Bisanti L, Bekura D, Morace G, et al. Ethiopian national hepatitis B study. J Med Virol. 1988;24(1):75\u201384.","journal-title":"J Med Virol"},{"key":"1448_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12481","author":"J Riou","year":"2015","unstructured":"Riou J, Ahmed M, Blake A, Vozlinsky S, Brichler S, et al. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. J Viral Hepat. 2015. https:\/\/doi.org\/10.1111\/jvh.12481.","journal-title":"J Viral Hepat"},{"key":"1448_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/jvh.12481","volume":"23","author":"J Riou","year":"2016","unstructured":"Riou J, A\u00eft Ahmed M, Blake A, Vozlinsky S, Brichler S, Eholi\u00e9 S, Bo\u00eblle P-Y, Fontanet A, and,. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. J Viral Hepat. 2016;23:244\u201355. https:\/\/doi.org\/10.1111\/jvh.12481.","journal-title":"J Viral Hepat"},{"key":"1448_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7370524","author":"MA Daw","year":"2016","unstructured":"Daw MA, et al. Hepatitis C virus in North Africa: an emerging threat. Sci World J. 2016. https:\/\/doi.org\/10.1155\/2016\/7370524.","journal-title":"Sci World J"}],"container-title":["Journal of Immigrant and Minority Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-022-01448-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10903-022-01448-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-022-01448-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T16:29:09Z","timestamp":1688056149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10903-022-01448-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1007\/s10903-022-01448-z","relation":{},"ISSN":["1557-1912","1557-1920"],"issn-type":[{"value":"1557-1912","type":"print"},{"value":"1557-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,14]]},"assertion":[{"value":"27 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As described above, written informed consent was obtained from study participants after briefing on CDC requirements for infectious disease screening. The nature of the UAT samples to be analyzed in this project were examined by the responsible ethics body of Benghazi University-Libyan. Recognizing the strict UAT control and unlinked demographic information with serum samples, the project was judged to not require further ethical oversight.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}